1. Home
  2. Live Updates
  3. லாரா ஸட்‌க்லிஃப்

Page 2 - லாரா ஸட்‌க்லிஃப் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from லாரா ஸட்‌க்லிஃப். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In லாரா ஸட்‌க்லிஃப் Today - Breaking & Trending Today

Novartis (NVS) Q1 2021 Earnings Call Transcript


Novartis (NVS) Q1 2021 Earnings Call Transcript
Motley Fool Transcribing
© The Motley Fool
Logo of jester cap with thought bubble.
Novartis (NYSE: NVS)
Good morning and good afternoon, and welcome to the Novartis Q1 2021 results release conference call and live audio webcast. Please note that during the presentation, all participants will be on a listen-only mode and the conference is being recorded. [Operator instructions] A recording of the conference call including the Q&A session will be available on our website shortly after the call ends. [Operator instructions] With that, I would like to hand it over to Mr.
Samir Shah, global head of investor relations. Please go ahead, sir. ....

United States , Czech Republic , Graham Parry , Matthew Weston , Andrew Baum , Susanne Schaffert , Laura Sutcliffe , Harry Kirsch , Samir Shah , Andrew Baum Citi , Simon Baker Redburn , Keyur Parekh , Mike Nedelcovych , Tom Kendris , John Tsai , Richard Parkes , Tim Anderson , Florent Cespedes , Richard Wagner , Societe Generale , Richard Parkes Exane , Florent Cespedes Societe Generale , Mark Purcell , Simon Baker , Exjade Jadenu , Emmanuel Papadakis ,

Galapagos NV (GLPG) Q4 2020 Earnings Call Transcript


Ladies and gentlemen, thank you for standing by and welcome to the Galapagos Conference Call.
I would now like to hand the conference to your speaker today, Elizabeth Goodwin. Please go ahead.
Elizabeth Goodwin
Vice President, Investor Relations
Thank you and welcome all to the audio webcast of Galapagos full year 2020 results. I m Elizabeth Goodwin, Investor Relations, also representing a great reporting team at Galapagos. This recorded webcast is accessible via our website homepage and will be available for download and replay later today.
I would like to remind everyone that we will be making forward-looking statements during today s webcast. These forward-looking statements include remarks concerning future developments of the pipeline in our company and possible changes in the industry and competitive environment because these forward-looking statements involve risks and uncertainties, Galapagos actual results may differ materially from the results ex ....

United States , Elizabeth Goodwin , Bart Filius , Laerke Engkilde , Laerke Engkilde Jpmorgan , Laura Sutcliffe , Galapagos Conference , Investor Relations , Data Safety Monitoring Board , Operating Officer , Chief Financial , ஒன்றுபட்டது மாநிலங்களில் , எலிசபெத் குட்வின் , லாரா ஸட்‌க்லிஃப் , க்யாலபாகொஸ் மாநாடு , முதலீட்டாளர் உறவுகள் , தகவல்கள் பாதுகாப்பு கண்காணிப்பு பலகை , இயங்குகிறது அதிகாரி , தலைமை நிதி ,

Why the three biggest vaccine makers failed on COVID-19


Why the three biggest vaccine makers failed on COVID-19
Hannah Kuchler and Leila Abboud
Feb 18, 2021 – 12.04pm
Save
Share
GlaxoSmithKline, Merck and Sanofi are now left playing catch-up, after upstarts including Moderna and BioNTech demonstrated their mastery of new technologies that will shape the industry for years to come.
The scarcity of vaccines around the world is directly connected to big pharma groups being missing in action. 
New Jersey-based Merck recently dropped its vaccine development program completely, while Paris-based Sanofi and the UK’s GSK are having to redo an early-stage trial of the jab they are jointly developing, after a dosing mistake. ....

United Kingdom , Ron Renaud , Dan Mahony , Thomas Breuer , Mansoor Amiji , Laura Sutcliffe , Peter Hotez , Merck Gardasil , Soren Christiansen , Jo Walton , Ken Frazier , Credit Suisse , Sharps Technology , Baylor College , Northeastern University , Baylor College Of Medicine , Oxford University , Translate Bio , Polar Capital , ஒன்றுபட்டது கிஂக்டம் , ரோன் ரிநோ , டான் மஹோனி , தாமஸ் ப்ரூவர் , மன்சூர் அமிஜி , லாரா ஸட்‌க்லிஃப் , புண் கிறிஸ்டியன்சன் ,

Covid 19 coronavirus: Why the three biggest vaccine makers failed on Covid-19


Covid 19 coronavirus: Why the three biggest vaccine makers failed on Covid-19
16 Feb, 2021 07:05 PM
9 minutes to read
GlaxoSmithKline, Merck and Sanofi are now left playing catch-up in the vaccine race. Photo / 123RF
Financial Times
GlaxoSmithKline, Merck and Sanofi are left playing catch-up to upstarts with new technology.
As pharmaceutical companies raced to develop Covid-19 vaccines, crossing the finishing line in record time, the world s three biggest vaccine makers were
also-rans.
GlaxoSmithKline, Merck and Sanofi are now left playing catch-up, after upstarts including Moderna and BioNTech demonstrated their mastery of new technologies that will shape the industry for years to come.
New Jersey-based Merck recently dropped its vaccine development programme completely, while Paris-based Sanofi and the UK s GSK are having to redo an early-stage trial of the jab they are jointly developing, after a dosing mistake. ....

United Kingdom , Zain Rizvi , Curevac Covid , Ron Renaud , Dan Mahony , Thomas Breuer , Hannah Kuchler , Leila Abboud , Mansoor Amiji , Laura Sutcliffe , Peter Hotez , Merck Gardasil , Soren Christiansen , Jo Walton , Ken Frazier , Credit Suisse , Sharps Technology , Baylor College , Baylor College Of Medicine , Jersey Based Merck , Paris Based Sanofi , Public Citizen , Translate Bio , Polar Capital , Co Vid , Corona Virus ,